Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recovery quality after bariatric surgery: xenon versus desflurane
2009-017126-39Phase 3Completed
- Sponsor
- CHU Nîmes
- Start
- Mar 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of xenon, desflurane and remifentanil in obesity (2 arms), sponsored by CHU Nîmes. Primary endpoint: Intermediate recovery at 30 minutes. Started Mar 2010; status: completed.
02
Drugs
xenondesfluraneremifentanil
03
Conditions
obesity
Beyond the preview
Go deeper on 2009-017126-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017126-39.